MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • MDS Virtual Congress 2020

    Helicobacter pylori eradication in Parkinson’s disease: A double-blind randomized placebo-controlled study

    A.H Tan, S.Y Lim, S. Mahadeva, M.F Loke, J.S Vadivelu, C. Marras, S.H Fox, A.E Lang (Kuala Lumpur, Malaysia)

    Objective: To evaluate the effects of Helicobacter pylori eradication on PD symptoms. Background: Globally, H. pylori infection remains a common problem. Cross-sectional studies in Parkinson's disease (PD)…
  • MDS Virtual Congress 2020

    The add-on effect of Lactobacillus plantarum PS128 in patients with Parkinson’s disease: A pilot study

    H.C Chang, Y.C Tsai, C.S Lu (Taoyuan City, Taiwan)

    Objective: We aimed to investigate the add-on effect of Lactobacillus plantarum PS128 (PS128) in patients with Parkinson’s disease (PD). Background: PS128 is a specific probiotic…
  • MDS Virtual Congress 2020

    Beta-adrenoreceptor medications and risk of Parkinson’s disease

    X. Li, L. Wang, Y. Zhang (Guangzhou, China)

    Objective: To review and analyze the associations between β-adrenoreceptor medications and risk of Parkinson's disease. Background: Distinctive Lewy body mainly composed of α-synuclein is an…
  • MDS Virtual Congress 2020

    Evaluation of Advanced Parkinson’s Patients Using Levodopa Carbidopa Instestinal Gel: Results of the Aegean Region of Turkey

    O. Yilmaz Kusbeci, A. Acarer, B. Donmez Colakoglu, I. Inci, R. Cakmur, A. Akyol, Z. Colakoglu (Izmir, Turkey)

    Objective: The aim of the present study was to evaluate the outcome of LCIG treatment in advanced PD in Aegean Region of Turkey. Background: Levodopa/carbidopa…
  • MDS Virtual Congress 2020

    Apomorphine as a Diagnostic tool to Identify Levodopa Responsive Atypical Parkinsonism

    M. Faisal, D. Sreenivasa, R. Jayachandran, R. Seetharam, R. Iyer, P. Kukkle (Bengaluru, India)

    Objective: To assess the efficacy of apomorphine in identification of levodopa responsive atypical parkinsonism. Background: Management of atypical parkinsonism is a challenge. Most of these…
  • MDS Virtual Congress 2020

    Clinical outcome of 6-pyruvoyl-tetrahydropterin synthase deficiency (PTPSd)

    F. Nardecchia, F. Manti, S. Galosi, A. Burlina, D. Gueraldi, M. Donati, F. Pochiero, a. Cassio, F. Porta, M. Spada, C. Carducci, C. Carducci, S. Paci, G. Banderali, M. Schiaffino, N. Blau, V. Leuzzi (Rome, Italy)

    Objective: To assess morbility and clinical outcome of patients affected by defect of tetrahydrobiopterin (BH4) synthesis due to PTPSd. Background: PTPSd is a treatable genetic disorder…
  • MDS Virtual Congress 2020

    A Virtual Speech Therapist for Parkinson’s Disease

    A. Halpern, L. Ramig, R. Cole (Denver, CO, USA)

    Objective: This study was designed as a pilot investigation to explore the use of virtual therapy in the delivery of LSVT LOUD ® (Lee Silverman…
  • MDS Virtual Congress 2020

    Concerns in patients with Parkinson’s disease in China: A content analysis of data from social listening

    Y. Qian, X. Yang, S. Xu, X. He, Y. Zhang, C. Mo, Q. Xiao (Shanghai, China)

    Objective: To understand Parkinson’s disease (PD) patients’ unmet needs and optimize the communication strategy with them, we used social media listening (SML) to focus on…
  • MDS Virtual Congress 2020

    Ambulatory Capacity Measure derived from the Movement Disorders Society Unified Parkinson’s Disease Rating Scale (MDS-UPDRS)

    C. Venuto, G. Smith, R. Zielinski, M. Javidnia, T. Simuni, K. Kieburtz (Rochester, NY, USA)

    Objective: (1) Construct a measure of ambulatory capacity derived from the MDS-UPDRS that is similarly structured to the original Ambulatory Capacity Measure (ACM) derived from…
  • MDS Virtual Congress 2020

    Establishment of a Visual Analog Scale (VAS) for DBS Programming (VISUAL – STIM Trial)

    C. Palleis, M. Gehmeyr, J. Mehrkens, K. Boetzel, T. Koeglsperger (Munich, Germany)

    Objective: With this study, we wanted to demonstrate a new strategy to adjust stimulation parameters and lead configurations, using a visual analog scale. Background: Deep brain…
  • « Previous Page
  • 1
  • …
  • 94
  • 95
  • 96
  • 97
  • 98
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley